Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression

NCT06760923 is registered in ClinicalTrials.gov with Xiangya Hospital of Central South University as lead sponsor.

NCT NCT06760923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06760923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Urinary Proteomic Assessment of Ovarian Malignancy and Disease Progression
Lead sponsor
Xiangya Hospital of Central South University
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2027
Enrollment
240 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer (ovca)